• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Protagonist Therapeutics Set to Join S&P SmallCap 600

    6/27/24 5:44:00 PM ET
    $PTGX
    $SPGI
    $WIRE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $PTGX alert in real time by email

    NEW YORK, June 27, 2024 /PRNewswire/ -- Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    July 3, 2024

    S&P SmallCap 600

    Addition

    Protagonist Therapeutics

    PTGX

    Health Care



    S&P SmallCap 600

    Deletion

    Encore Wire

    WIRE

    Industrials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/protagonist-therapeutics-set-to-join-sp-smallcap-600-302185154.html

    SOURCE S&P Dow Jones Indices

    Get the next $PTGX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $PTGX
    $SPGI
    $WIRE

    CompanyDatePrice TargetRatingAnalyst
    Protagonist Therapeutics Inc.
    $PTGX
    6/17/2025$72.00Buy
    Citigroup
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    S&P Global Inc.
    $SPGI
    12/20/2024$600.00Buy
    Citigroup
    Protagonist Therapeutics Inc.
    $PTGX
    12/6/2024$47.00Neutral
    Goldman
    Protagonist Therapeutics Inc.
    $PTGX
    12/6/2024$62.00Outperform
    BMO Capital Markets
    Protagonist Therapeutics Inc.
    $PTGX
    11/5/2024$58.00Outperform
    Wedbush
    S&P Global Inc.
    $SPGI
    10/2/2024$599.00Outperform
    Evercore ISI
    More analyst ratings

    $PTGX
    $SPGI
    $WIRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • S&P Dow Jones Indices Reports U.S. Common Indicated Dividend Payments Increase of $7.4 Billion in Q2 2025 as Dividend Growth Continues to Slow

      Q2 2025 U.S. common dividend increases were $9.8 billion, down 49.8% from $19.5 billion in Q1 2025 and down 52.1% from $20.4 billion in Q2 2024.Q2 2025 U.S. common dividend decreases were $2.3 billion, down 44.0% from $4.2 billion in Q1 2025, and down 46.8% from $4.4 billion in Q2 2024.Q2 2025 net indicated dividend rate change increased $7.4 billion. For the 12-months ending June 2025, U.S. common dividend increases were $57.6 billion down 26.8% from the 12-month June 2024 period's $78.7 billion; decreases were down 43.9% to $13.5 billion compared to $24.1 billion for the prior 12-month period.The net 12-month June 2025 indicated dividend increase was $44.1 billion compared to $54.6 billion

      7/7/25 9:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Datadog Set to Join S&P 500

      NEW YORK, July 2, 2025 /PRNewswire/ -- Datadog Inc. (NASD: DDOG) will replace Juniper Networks Inc. (NYSE:JNPR) in the S&P 500 effective prior to the opening of trading on Wednesday, July 9. S&P 500 constituent Hewlett Packard Enterprise Co. (NYSE:HPE) acquired Juniper Networks on July 2.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 9, 2025 S&P 500 Addition Datadog DDOG Information Technology July 9, 2025 S&P 500 Deletion Juniper Networks JNPR Information Technology For more information about S&P Dow Jones Indices, please visit www.spdji.com ABOUT S&

      7/2/25 5:55:00 PM ET
      $DDOG
      $HPE
      $JNPR
      $SPGI
      Computer Software: Prepackaged Software
      Technology
      Retail: Computer Software & Peripheral Equipment
      Computer Communications Equipment
    • S&P Dow Jones Indices Announces Update to S&P Composite 1500 Market Cap Guidelines

      NEW YORK, July 1, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") is updating the market capitalization eligibility criteria for additions to the S&P Composite 1500 Indices. Effective July 1, 2025, the size ranges will be updated as follows: Previous Market Capitalization Eligibility Criteria Updated Market Capitalization Eligibility Criteria Unadjusted company market capitalization of: •  US$ 20.5 billion or more for the S&P 500 •  US$ 7.4 billion to US$ 20.5 billion for the S&P    MidCap 400 •  US$ 1.1 billion to US$ 7.4 billion for the S&P    SmallCap 600 Unadjusted company market capitalization of: •  US$ 22.7 billion or more for the S&P 500 •  US$ 8.0 billion to US$ 22.7 billi

      7/1/25 5:40:00 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $PTGX
    $SPGI
    $WIRE
    SEC Filings

    See more
    • Protagonist Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Protagonist Therapeutics, Inc (0001377121) (Filer)

      6/26/25 4:08:54 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 11-K filed by S&P Global Inc.

      11-K - S&P Global Inc. (0000064040) (Filer)

      6/25/25 6:16:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • SEC Form SCHEDULE 13G filed by Protagonist Therapeutics Inc.

      SCHEDULE 13G - Protagonist Therapeutics, Inc (0001377121) (Subject)

      6/16/25 5:30:24 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PTGX
    $SPGI
    $WIRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      6/17/24 4:04:40 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $PTGX
    $SPGI
    $WIRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup initiated coverage on Protagonist Therapeutics with a new price target

      Citigroup initiated coverage of Protagonist Therapeutics with a rating of Buy and set a new price target of $72.00

      6/17/25 7:50:36 AM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BofA Securities resumed coverage on S&P Global with a new price target

      BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $600.00

      4/10/25 8:19:38 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Mizuho initiated coverage on S&P Global with a new price target

      Mizuho initiated coverage of S&P Global with a rating of Outperform and set a new price target of $599.00

      3/12/25 7:34:28 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $PTGX
    $SPGI
    $WIRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Patel Dinesh V Ph D gifted 1,355 shares, decreasing direct ownership by 0.24% to 562,905 units (SEC Form 4)

      4 - Protagonist Therapeutics, Inc (0001377121) (Issuer)

      6/17/25 4:01:12 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Medical Officer Molina Arturo Md exercised 20,000 shares at a strike of $8.04 and sold $1,125,400 worth of shares (20,000 units at $56.27) (SEC Form 4)

      4 - Protagonist Therapeutics, Inc (0001377121) (Issuer)

      6/11/25 5:40:40 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • EVP, Chief Client Officer Moore Sally sold $255,148 worth of shares (500 units at $510.43), decreasing direct ownership by 9% to 5,131 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      5/7/25 5:33:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $PTGX
    $SPGI
    $WIRE
    Financials

    Live finance-specific insights

    See more
    • S&P Dow Jones Indices Reports U.S. Common Indicated Dividend Payments Increase of $7.4 Billion in Q2 2025 as Dividend Growth Continues to Slow

      Q2 2025 U.S. common dividend increases were $9.8 billion, down 49.8% from $19.5 billion in Q1 2025 and down 52.1% from $20.4 billion in Q2 2024.Q2 2025 U.S. common dividend decreases were $2.3 billion, down 44.0% from $4.2 billion in Q1 2025, and down 46.8% from $4.4 billion in Q2 2024.Q2 2025 net indicated dividend rate change increased $7.4 billion. For the 12-months ending June 2025, U.S. common dividend increases were $57.6 billion down 26.8% from the 12-month June 2024 period's $78.7 billion; decreases were down 43.9% to $13.5 billion compared to $24.1 billion for the prior 12-month period.The net 12-month June 2025 indicated dividend increase was $44.1 billion compared to $54.6 billion

      7/7/25 9:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • S&P Global Schedules Second Quarter 2025 Earnings Announcement and Conference Call for Thursday, July 31, 2025

      NEW YORK, June 26, 2025 /PRNewswire/ -- S&P Global's (NYSE:SPGI) second quarter 2025 results will be issued on Thursday, July 31, 2025 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on July 31, 2025 to discuss the Company's second quarter 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, supplemental deck, a

      6/26/25 4:00:00 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • S&P 500 Q1 2025 Buybacks Set Quarterly Record at $293 Billion, Up 20.6%, Helping EPS Growth; Impact and Expenditures Expected to Decline in Q2 2025

      S&P 500 Q1 2025 buybacks were $293.5 billion, setting a quarterly record, previously held by Q1 2022's $281.0 billion expenditure (when prices were 23.9% lower), and were up 20.6% from Q4 2024's $243.2 billion and up 23.9% from Q1 2024's $236.8 billionThe 12-month March 2025 expenditure was $999.2 billion and was up 22.4% from the 12-month March 2024 expenditure of $816.5 billion Communication Services increased spending by 56.5% and Information Technology increased 25.8%, as Consumer Staples and Consumer Discretionary reduced their spending by 25.6% and 16.8%, respectively The net buyback 1% tax reduced Q1 2025 operating earnings by 0.50% and As Reported GAAP by 0.53%, as the 12-month cost

      6/25/25 9:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $PTGX
    $SPGI
    $WIRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Protagonist Therapeutics Inc.

      SC 13G/A - Protagonist Therapeutics, Inc (0001377121) (Subject)

      11/14/24 4:27:37 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Protagonist Therapeutics Inc.

      SC 13G/A - Protagonist Therapeutics, Inc (0001377121) (Subject)

      11/12/24 4:51:49 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Protagonist Therapeutics Inc.

      SC 13G/A - Protagonist Therapeutics, Inc (0001377121) (Subject)

      11/4/24 1:22:14 PM ET
      $PTGX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PTGX
    $SPGI
    $WIRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Datadog Set to Join S&P 500

      NEW YORK, July 2, 2025 /PRNewswire/ -- Datadog Inc. (NASD: DDOG) will replace Juniper Networks Inc. (NYSE:JNPR) in the S&P 500 effective prior to the opening of trading on Wednesday, July 9. S&P 500 constituent Hewlett Packard Enterprise Co. (NYSE:HPE) acquired Juniper Networks on July 2.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 9, 2025 S&P 500 Addition Datadog DDOG Information Technology July 9, 2025 S&P 500 Deletion Juniper Networks JNPR Information Technology For more information about S&P Dow Jones Indices, please visit www.spdji.com ABOUT S&

      7/2/25 5:55:00 PM ET
      $DDOG
      $HPE
      $JNPR
      $SPGI
      Computer Software: Prepackaged Software
      Technology
      Retail: Computer Software & Peripheral Equipment
      Computer Communications Equipment
    • Ralliant Set to Join S&P SmallCap 600

      NEW YORK, June 25, 2025 /PRNewswire/ -- Ralliant Corp. (NYSE:RAL) will replace Wolfspeed Corp. (NYSE:WOLF) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 1. S&P 500 constituent Fortive Corp. (NYSE:FTV) is spinning off Ralliant in a transaction expected to be completed on June 30. Fortive will remain in the S&P 500 post spin-off. Wolfspeed announced its intention to file for bankruptcy on or before July 1 and is therefore no longer eligible for continued inclusion in the S&P SmallCap 600. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker

      6/25/25 6:12:00 PM ET
      $FTV
      $SPGI
      $WOLF
      Industrial Machinery/Components
      Industrials
      Finance: Consumer Services
      Finance
    • APi Group Set to Join S&P MidCap 400

      NEW YORK, June 18, 2025 /PRNewswire/ -- APi Group Corp. (NYSE:APG) will replace United States Steel Corp. (NYSE:X) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, June 24. Nippon Steel Corp. (TSE: 5401) acquired United States Steel in a deal that closed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date  Index Name  Action  Company Name  Ticker  GICS Sector   June 24, 2025   S&P MidCap 400  Addition  APi Group   APG  Industrials   June 24, 2025   S&P MidCap 400  Deletion  United States Steel  X  Materials  For more information about S&P Dow Jones Indices, please visit www.spdji.com

      6/18/25 5:46:00 PM ET
      $APG
      $SPGI
      $X
      Engineering & Construction
      Consumer Discretionary
      Finance: Consumer Services
      Finance